<DOC>
	<DOCNO>NCT01369485</DOCNO>
	<brief_summary>The purpose study evaluate change baseline active sham treatment group treatment urgency ( urinary ) incontinence episode ( leak ) .</brief_summary>
	<brief_title>Safety Effectiveness Non-invasive Neuromodulation Device Urgency Urinary Incontinence Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Males Females , least 18 year age Failure primary OAB treatment , behavior modification fluid/diet management , AND least one ( 1 ) anticholinergic drug ( unless patient contraindicate anticholinergic use ) Symptoms overactive bladder least 6 month An average one ( 1 ) urgency ( urinary ) incontinence episode per 24hours , 3day period , confirm 3day baseline void diary , maximum 12 urgency ( urinary ) incontinence episode per 24hours Dexterity ability place operate device Females childbearing capability agree use reliable form birth control duration trial An average eight ( 8 ) void per 24hours , 3day period , confirm 3day baseline void diary Willing capable understanding complying requirement protocol , include proper completion baseline void diary Signed date IRBapproved Informed Consent document . Dysfunctional voiding symptom unrelated OAB , clinically significant bladder outlet obstruction , urinary retention ( pvr &gt; 100 cc ) Morbidly obese , define Body Mass Index ( BMI ) &gt; 40 kg/m2 Stress predominant mix urinary incontinence Neurological disease affect urinary bladder function , include limited Parkinson 's disease , multiple sclerosis , stroke , spinal cord injury uncontrolled epilepsy . Pelvic surgery ( suburethral sling , pelvic floor repair ) within past 6 month Intravesical urethral sphincter Botulinum Toxin Type A injection within past 12 month Any neuromodulation therapy overactive bladder within past 3 month Failure respond previous neuromodulation therapy overactive bladder Leading edge vaginal prolapse beyond hymenel ring . Prior periurethral transurethral bulking agent injection bladder problem within past 12 month . Any skin condition affect treatment assessment treatment sit History low back surgery injury could impact placement patch , underlie scar tissue nerve damage may impact treatment . Presence implant electromedical device ( e.g . pacemaker , defibrillator , InterStimÂ® , etc . ) , metallic implant lower back . Pregnant , nursing , suspect pregnant ( urine pregnancy method ) , plan become pregnant course study . Known latex allergy , allergy hypersensitivity patch material contact body ( e.g. , hydrogel , acrylicbased adhesive , polyurethane ) . Uncontrolled diabetes and/or diabetes peripheral neuropathy . Current Urinary Tract Infection ( UTI ) history recurrent UTIs ( &gt; 3 UTIs past year ) . History low tract genitourinary malignancy within last 6 month previous pelvic radiation . Any clinically significant systemic disease condition opinion Investigator would make patient unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Urinary Incontinence</keyword>
	<keyword>Overactive Bladder</keyword>
	<keyword>Frequency</keyword>
	<keyword>Urgency</keyword>
</DOC>